Diabetes, Vol 36, Issue 10 1187-1194, Copyright © 1987 by American Diabetes Association

ARTICLES

Effects of fasting on plasma glucose and prolonged tracer measurement of hepatic glucose output in NIDDM

H Glauber, P Wallace and G Brechtel
Department of Medicine, University of California, San Diego, La Jolla 92093.

We studied the measurement of hepatic glucose output (HGO) with prolonged [3-3H]glucose infusion in 14 patients with non-insulin-dependent diabetes mellitus (NIDDM). Over the course of 10.5 h, plasma glucose concentration fell with fasting by one-third, from 234 +/- 21 to 152 +/- 12 mg/dl, and HGO fell from 2.35 +/- 0.18 to 1.36 +/- 0.07 mg . kg-1 . min-1 (P less than .001). In the basal state, HGO and glucose were significantly correlated (r = 0.68, P = .03), and in individual patients, HGO and glucose were closely correlated as both fell with fasting (mean r = 0.79, P less than .01). Plasma [3-3H]glucose radioactivity approached a steady state only 5-6 h after initiation of the primed continuous infusion, and a 20% overestimate of HGO was demonstrated by not allowing sufficient time for tracer labeling of the glucose pool. Assumption of steady-state instead of non-steady-state kinetics in using Steele's equations to calculate glucose turnover resulted in a 9-24% overestimate of HGO. Stimulation of glycogenolysis by glucagon injection demonstrated no incorporation of [3-3H]glucose in hepatic glycogen during the prolonged tracer infusion. In a separate study, plasma glucose was maintained at fasting levels (207 +/- 17 mg/dl) for 8 h with the glucose-clamp technique. Total glucose turnover rates remained constant during this prolonged tracer infusion. However, HGO fell to 30% of the basal value simply by maintaining fasting hyperglycemia in the presence of basal insulin levels.(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. Basu, W. F. Schwenk, and R. A. Rizza Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E55 - E62. [Abstract] [Full Text] [PDF]

				S. K. Tigas, A. L. Sunehag, and M. W. Haymond Impact of Duration of Infusion and Choice of Isotope Label on Isotope Recycling in Glucose Homeostasis Diabetes, November 1, 2002; 51(11): 3170 - 3175. [Abstract] [Full Text] [PDF]

				N. Ercan-Fang, M. C. Gannon, V. L. Rath, J. L. Treadway, M. R. Taylor, and F. Q. Nuttall Integrated effects of multiple modulators on human liver glycogen phosphorylase a Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E29 - E37. [Abstract] [Full Text] [PDF]